AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Gastrointest Liver Physiol 287: G7-G17, 2004; doi:10.1152/ajpgi.00079.2004
0193-1857/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (124)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Itzkowitz, S. H.
Right arrow Articles by Yio, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Itzkowitz, S. H.
Right arrow Articles by Yio, X.

THEMES

Inflammation and Cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation

Steven H. Itzkowitz and Xianyang Yio

Gastrointestinal Division, Mount Sinai School of Medicine, New York, New York 10029

Patients with ulcerative colitis and Crohn's disease are at increased risk for developing colorectal cancer. To date, no known genetic basis has been identified to explain colorectal cancer predisposition in these inflammatory bowel diseases. Instead, it is assumed that chronic inflammation is what causes cancer. This is supported by the fact that colon cancer risk increases with longer duration of colitis, greater anatomic extent of colitis, the concomitant presence of other inflammatory manifestations such as primary sclerosing cholangitis, and the fact that certain drugs used to treat inflammation, such as 5-aminosalicylates and steroids, may prevent the development of colorectal cancer. The major carcinogenic pathways that lead to sporadic colorectal cancer, namely chromosomal instability, microsatellite instability, and hypermethylation, also occur in colitis-associated colorectal cancers. Unlike normal colonic mucosa, however, inflamed colonic mucosa demonstrates abnormalities in these molecular pathways even before any histological evidence of dysplasia or cancer. Whereas the reasons for this are unknown, oxidative stress likely plays a role. Reactive oxygen and nitrogen species produced by inflammatory cells can interact with key genes involved in carcinogenic pathways such as p53, DNA mismatch repair genes, and even DNA base excision-repair genes. Other factors such as NF-{kappa}B and cyclooxygenases may also contribute. Administering agents that cause colitis in healthy rodents or genetically engineered cancer-prone mice accelerates the development of colorectal cancer. Mice genetically prone to inflammatory bowel disease also develop colorectal cancer especially in the presence of bacterial colonization. These observations offer compelling support for the role of inflammation in colon carcinogenesis.

inflammatory bowel disease; colorectal cancer; colitis; oxidative stress; animal models


Address for reprint requests and other correspondence: S. H. Itzkowitz, GI Division, Box 1069, Mount Sinai School of Medicine, One Gustave Levy Place, New York, NY 10029 (E-mail: steven.itzkowitz{at}msnyuhealth.org).




This article has been cited by other articles:


Home page
 CarcinogenesisHome page
O. Turovskaya, D. Foell, P. Sinha, T. Vogl, R. Newlin, J. Nayak, M. Nguyen, A. Olsson, P. P. Nawroth, A. Bierhaus, et al.
RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis
Carcinogenesis, October 1, 2008; 29(10): 2035 - 2043.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
L. Roncucci, E. Mora, F. Mariani, S. Bursi, A. Pezzi, G. Rossi, M. Pedroni, D. Luppi, L. Santoro, S. Monni, et al.
Myeloperoxidase-Positive Cell Infiltration in Colorectal Carcinogenesis as Indicator of Colorectal Cancer Risk
Cancer Epidemiol. Biomarkers Prev., September 1, 2008; 17(9): 2291 - 2297.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Prevention ResearchHome page
M. Shimizu, Y. Shirakami, H. Sakai, S. Adachi, K. Hata, Y. Hirose, H. Tsurumi, T. Tanaka, and H. Moriwaki
(-)-Epigallocatechin Gallate Suppresses Azoxymethane-Induced Colonic Premalignant Lesions in Male C57BL/KsJ-db/db Mice
Cancer Prevention Research, September 1, 2008; 1(4): 298 - 304.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
M W M D Lutgens, F P Vleggaar, M E I Schipper, P C F Stokkers, C J van der Woude, D W Hommes, D J de Jong, G Dijkstra, A A van Bodegraven, B Oldenburg, et al.
High frequency of early colorectal cancer in inflammatory bowel disease
Gut, September 1, 2008; 57(9): 1246 - 1251.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
V. S. Kotakadi, Y. Jin, A. B. Hofseth, L. Ying, X. Cui, S. Volate, A. Chumanevich, P. A. Wood, R. L. Price, A. McNeal, et al.
Ginkgo biloba extract EGb 761 has anti-inflammatory properties and ameliorates colitis in mice by driving effector T cell apoptosis
Carcinogenesis, September 1, 2008; 29(9): 1799 - 1806.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Prevention ResearchHome page
T. O. Khor, M.-T. Huang, A. Prawan, Y. Liu, X. Hao, S. Yu, W. K. L. Cheung, J. Y. Chan, B. S. Reddy, C. S. Yang, et al.
Increased Susceptibility of Nrf2 Knockout Mice to Colitis-Associated Colorectal Cancer
Cancer Prevention Research, August 1, 2008; 1(3): 187 - 191.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
K Assi, J Mills, D Owen, C Ong, R St Arnaud, S Dedhar, and B Salh
Integrin-linked kinase regulates cell proliferation and tumour growth in murine colitis-associated carcinogenesis
Gut, July 1, 2008; 57(7): 931 - 940.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
C Campregher, M G Luciani, and C Gasche
Activated neutrophils induce an hMSH2-dependent G2/M checkpoint arrest and replication errors at a (CA)13-repeat in colon epithelial cells
Gut, June 1, 2008; 57(6): 780 - 787.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
C. Semino-Mora, H. Liu, T. McAvoy, C. Nieroda, K. Studeman, A. Sardi, and A. Dubois
Pseudomyxoma Peritonei: Is Disease Progression Related to Microbial Agents? A Study of Bacteria, MUC2 and MUC5AC Expression in Disseminated Peritoneal Adenomucinosis and Peritoneal Mucinous Carcinomatosis
Ann. Surg. Oncol., May 1, 2008; 15(5): 1414 - 1423.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
F. Biasi, C. Mascia, and G. Poli
The contribution of animal fat oxidation products to colon carcinogenesis, through modulation of TGF-{beta}1 signaling
Carcinogenesis, May 1, 2008; 29(5): 890 - 894.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
J. Zabaleta, H.-Y. Lin, R. A. Sierra, M.C. Hall, P. E. Clark, O. A. Sartor, J. J. Hu, and A. C. Ochoa
Interactions of cytokine gene polymorphisms in prostate cancer risk
Carcinogenesis, March 1, 2008; 29(3): 573 - 578.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
E Burum-Auensen, P M DeAngelis, A R Schjolberg, J. Roislien, S N Andersen, and O P F Clausen
Spindle proteins Aurora A and BUB1B, but not Mad2, are aberrantly expressed in dysplastic mucosa of patients with longstanding ulcerative colitis
J. Clin. Pathol., December 1, 2007; 60(12): 1403 - 1408.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
D. Z. J. Chu, G. Gibson, D. David, and Y. Yen
The Surgeon's Role in Cancer Prevention. The Model in Colorectal Carcinoma
Ann. Surg. Oncol., November 1, 2007; 14(11): 3054 - 3069.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
W.-C. L. Chang, R. A. Coudry, M. L. Clapper, X. Zhang, K.-L. Williams, C. S. Spittle, T. Li, and H. S. Cooper
Loss of p53 enhances the induction of colitis-associated neoplasia by dextran sulfate sodium
Carcinogenesis, November 1, 2007; 28(11): 2375 - 2381.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Fang, J. Dean, and J. W. Smith
A Novel Variant of Ileal Bile Acid Binding Protein Is Up-regulated through Nuclear Factor-{kappa}B Activation in Colorectal Adenocarcinoma
Cancer Res., October 1, 2007; 67(19): 9039 - 9046.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
T. Imai, K. Fukuta, M. Hasumura, Y.-M. Cho, Y. Ota, S. Takami, H. Nakagama, and M. Hirose
Significance of inflammation-associated regenerative mucosa characterized by Paneth cell metaplasia and {beta}-catenin accumulation for the onset of colorectal carcinogenesis in rats initiated with 1,2-dimethylhydrazine
Carcinogenesis, October 1, 2007; 28(10): 2199 - 2206.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
J. Gommeaux, C. Cano, S. Garcia, M. Gironella, S. Pietri, M. Culcasi, M.-J. Pebusque, B. Malissen, N. Dusetti, J. Iovanna, et al.
Colitis and Colitis-Associated Cancer Are Exacerbated in Mice Deficient for Tumor Protein 53-Induced Nuclear Protein 1
Mol. Cell. Biol., March 15, 2007; 27(6): 2215 - 2228.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
K. Bedard and K.-H. Krause
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Physiol Rev, January 1, 2007; 87(1): 245 - 313.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
K. A. Park, H. S. Byun, M. Won, K.-J. Yang, S. Shin, L. Piao, J. M. Kim, W.-H. Yoon, E. Junn, J. Park, et al.
Sustained activation of protein kinase C downregulates nuclear factor-{kappa}B signaling by dissociation of IKK-{gamma} and Hsp90 complex in human colonic epithelial cells
Carcinogenesis, January 1, 2007; 28(1): 71 - 80.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
R. S. Chapkin, L. A. Davidson, L. Ly, B. R. Weeks, J. R. Lupton, and D. N. McMurray
Immunomodulatory Effects of (n-3) Fatty Acids: Putative Link to Inflammation and Colon Cancer
J. Nutr., January 1, 2007; 137(1): 200S - 204S.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. O. Khor, M.-T. Huang, K. H. Kwon, J. Y. Chan, B. S. Reddy, and A.-N. Kong
Nrf2-Deficient Mice Have an Increased Susceptibility to Dextran Sulfate Sodium-Induced Colitis
Cancer Res., December 15, 2006; 66(24): 11580 - 11584.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
Q. Cai, Y.-T. Gao, W.-H. Chow, X.-O. Shu, G. Yang, B.-T. Ji, W. Wen, N. Rothman, H.-L. Li, J. D. Morrow, et al.
Prospective Study of Urinary Prostaglandin E2 Metabolite and Colorectal Cancer Risk
J. Clin. Oncol., November 1, 2006; 24(31): 5010 - 5016.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D.-H. Lee, R. S. Esworthy, C. Chu, G. P. Pfeifer, and F.-F. Chu
Mutation accumulation in the intestine and colon of mice deficient in two intracellular glutathione peroxidases.
Cancer Res., October 15, 2006; 66(20): 9845 - 9851.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
X. Wang, Q. Wang, K. L. Ives, and B. M. Evers
Curcumin Inhibits Neurotensin-Mediated Interleukin-8 Production and Migration of HCT116 Human Colon Cancer Cells.
Clin. Cancer Res., September 15, 2006; 12(18): 5346 - 5355.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
T. Hanada, T. Kobayashi, T. Chinen, K. Saeki, H. Takaki, K. Koga, Y. Minoda, T. Sanada, T. Yoshioka, H. Mimata, et al.
IFN{gamma}-dependent, spontaneous development of colorectal carcinomas in SOCS1-deficient mice
J. Exp. Med., June 12, 2006; 203(6): 1391 - 1397.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
J. Vanamala, T. Leonardi, B. S. Patil, S. S. Taddeo, M. E. Murphy, L. M. Pike, R. S. Chapkin, J. R. Lupton, and N. D. Turner
Suppression of colon carcinogenesis by bioactive compounds in grapefruit
Carcinogenesis, June 1, 2006; 27(6): 1257 - 1265.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
N. P. Nunez, W.-J. Oh, J. Rozenberg, C. Perella, M. Anver, J. C. Barrett, S. N. Perkins, D. Berrigan, J. Moitra, L. Varticovski, et al.
Accelerated Tumor Formation in a Fatless Mouse with Type 2 Diabetes and Inflammation.
Cancer Res., May 15, 2006; 66(10): 5469 - 5476.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
H. Lu, W. Ouyang, and C. Huang
Inflammation, a Key Event in Cancer Development
Mol. Cancer Res., April 1, 2006; 4(4): 221 - 233.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
U. Peters, N. Chatterjee, T. R. Church, C. Mayo, S. Sturup, C. B. Foster, A. Schatzkin, and R. B. Hayes
High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal cancer early detection program.
Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 315 - 320.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
R. Suzuki, H. Kohno, S. Sugie, H. Nakagama, and T. Tanaka
Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice
Carcinogenesis, January 1, 2006; 27(1): 162 - 169.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. H. Kroenke, T. T. Fung, F. B. Hu, and M. D. Holmes
Dietary Patterns and Survival After Breast Cancer Diagnosis
J. Clin. Oncol., December 20, 2005; 23(36): 9295 - 9303.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
L. Basterfield, J. M.H.M. Reul, and J. C. Mathers
Impact of Physical Activity on Intestinal Cancer Development in Mice
J. Nutr., December 1, 2005; 135(12): 3002S - 3008S.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
K. E. Barrett
A new twist on trefoils. Focus on "TFF3 modulates NF-{kappa}B and a novel regulatory molecule of NF-{kappa}B in intestinal epithelial cells via a mechanism distinct from TNF-{alpha}"
Am J Physiol Cell Physiol, November 1, 2005; 289(5): C1069 - C1071.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
R. M. Peek Jr., S. Mohla, and R. N. DuBois
Inflammation in the Genesis and Perpetuation of Cancer: Summary and Recommendations from a National Cancer Institute-Sponsored Meeting
Cancer Res., October 1, 2005; 65(19): 8583 - 8586.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
R. Chen, P. S. Rabinovitch, D. A. Crispin, M. J. Emond, M. P. Bronner, and T. A. Brentnall
The initiation of colon cancer in a chronic inflammatory setting
Carcinogenesis, September 1, 2005; 26(9): 1513 - 1519.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
K. Schoonjans, L. Dubuquoy, J. Mebis, E. Fayard, O. Wendling, C. Haby, K. Geboes, and J. Auwerx
Liver receptor homolog 1 contributes to intestinal tumor formation through effects on cell cycle and inflammation
PNAS, February 8, 2005; 102(6): 2058 - 2062.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. M. Bertagnolli
Surgical Prevention of Cancer
J. Clin. Oncol., January 10, 2005; 23(2): 324 - 332.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.